Navigation Links
Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017
Date:12/2/2008

At Least 10 New Cellular Therapies Will Launch Over Next Decade, According to a New Report from Decision Resources

WALTHAM, Mass., Dec. 2 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the cellular therapies drug market will experience robust growth in the United States over the next decade, reaching $1.5 billion in 2017. According to the new special report entitled Cellular Therapies, the launch of second-generation cellular therapies, the approval of novel stem-cell-based therapies and dendritic cell vaccines, and the continuous adoption of existing cellular products will drive this market to grow at an annual rate of least 31 percent in the United States from 2007 to 2017.

While market growth will be strong in the United States, new centralized regulations in Europe that take effect at the end of 2008 will introduce uncertainties for cellular therapies marketed in Europe, according to the report. Among emerging therapies, TiGenix's ChondroCelect will be the first therapy to be reviewed under the new centralized European Medicines Agency guidelines.

The report forecasts that, of the 10 or more cellular therapies that will launch over the next decade in the United States and/or Europe, Dendreon's Provenge will be the first market entrant following its approval for prostate cancer in 2009 in the United States. Another cellular therapy that will launch in the near-term, Osiris/Genzyme's Prochymal, will garner sales of $235 million in 2017 for the treatment of Crohn's disease, although its initial regulatory approval will be for graft-versus-host disease in 2010 in the United States and in 2011 in Europe.

"First-to-market cellular therapies have had disappointing sales performances to date," said Irene Koulinska, M.D., analyst at Decision Resources. "However, researchers have ma
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
2. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
3. LCA-Vision to Present at RBC Capital Markets 2008 Healthcare Conference
4. New Marketing Coaching and Consulting Firm for Physicians Practicing Concierge Medicine Launched Today
5. TEAC Forms Strategic Alliance With SST Group, Inc. to Distribute Its Next Generation Medical Disc Publishing Systems Into Medical Market
6. CCID Consulting Discusses Chinas Medical Equipment Market
7. Valensa International and Parry Nutraceuticals Join Forces in the Global Natural Products Marketplace
8. STAR Marketing Announces New Breed of Healthcare Relationship Marketing Service
9. MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States
10. Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008
11. Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... May 19, 2013 According to ... Analysis and Forecast (2013 – 2018): By Applications ... Industrial)); Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) ... image sensor market was $8.00 billion in 2012 ... 2018, at an estimated CAGR of 3.84% from ...
(Date:5/19/2013)... New York, New York (PRWEB) May 19, 2013 ... note that a Case Management Conference was recently convened ... in a federal multidistrict litigation now underway in U.S. ... Minutes posted on the Court’s website on May 14th, ... motions. It was also reported during the Conference ...
(Date:5/19/2013)... Vegas Hotel Escapes, the premier Las ... launch it's all new vacation packages for the upcoming ... Consumers traveling to Las Vegas will be pleased to ... website. Travelers will be pleased to know that VegasHotelEscapes.com ... Vegas Hotel Escapes specializes in helping consumers Las ...
(Date:5/19/2013)... Beginning Wednesday, May 29 and running through Wednesday, August ... “Hot Dog Wednesdays" and Ice Cold Slushies at donor centers ... and all the fixin's to donors on Wednesdays. RRVBC ... “Donors are our lifeline. The summer months are an especially ... This is a small way for us to thank ...
(Date:5/19/2013)... The legal team at Pulaski & ... concerted effort to connect women and families coping with ... Yaz, Yasmin & Ocella with the legal representation they ... the notorious birth control drugs as well as news ... Yaz, Yasmin & Ocella were very popular birth control ...
Breaking Medicine News(10 mins):Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2
... Live Event ... Optimize Available Resources , ... VA (PRWEB) May 11, 2010 -- Harmony Information Systems Inc ., the leader in ... Vermont and Pennsylvania Are Taking Control of Medicaid Waivers Management ,” scheduled for Wednesday, May ...
... ... an Interpretive Dance Video. , ... Seattle, WA (PRWEB) May 11, 2010 -- Onlineshoes.com is proud to announce ... campaign featuring an interpretive dance video. , , ,Pronounced “cushy”, Cushe is a ...
... ... been recognized as a silver SugarCRM implementation partner providing best-practice implementation services ... the last two years as a leading player in producing advanced sales and marketing ... ...
... Melanoma and ... is linked to cancer risk. Practical and clinical information about skin health, melanoma and skin ... , ... -- With skin cancer on the rise for Americans under 30 and indoor tanning contributing ...
... ... million in a medical malpractice case against an obstetrician who delayed a C-section while the baby ... Division, Essex County, Docket No.: ESX-L-1906-08. , ... (PRWEB) May 11, 2010 -- On April 29, 2010 an Essex County, New Jersey jury ...
... ... noise , ... 11, 2010 -- Noisy construction by the MTA is keeping some residents in Brooklyn up ... have had no effect. Construction accident attorneys in New York are familiar with the ...
Cached Medicine News:Health News:Harmony Information Systems to Host Free Webcast: Learn How Vermont and Pennsylvania Are Taking Control of Medicaid Waivers Management 2Health News:Harmony Information Systems to Host Free Webcast: Learn How Vermont and Pennsylvania Are Taking Control of Medicaid Waivers Management 3Health News:Onlineshoes.com and Cushe Team Up to Offer Men and Women Shoes for Casual Living 2Health News:Onlineshoes.com and Cushe Team Up to Offer Men and Women Shoes for Casual Living 3Health News:ApexTwo and SugarCRM Announce New Implementation Partnership 2Health News:Skincancer.com Launches With Latest News, Information and Help for Consumers/Patients and Physicians 2Health News:Skincancer.com Launches With Latest News, Information and Help for Consumers/Patients and Physicians 3Health News:$18.5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C-Section 2Health News:New York Construction Accident Attorney, David Perecman, Supports MTA Night Work 2
(Date:5/16/2013)... OAKS, Calif. , May 16, 2013  Amgen (NASDAQ: ... Life Sciences Conference on Tuesday, May 21, 2013, at the ... City , beginning at 10:00 a.m. Eastern Daylight Time. ... vice president of Research and Development at Amgen, will present ... accessed from the Events Calendar on Amgen,s website, www.amgen.com ...
(Date:5/16/2013)... , May 16, 2013 ... in the U.S. to access the widely-used OrthoView digital ... PC and Internet connection to get started. ... software for over 10 years, is dedicated to enabling ... with digital x-ray images, when printed film is unavailable. ...
(Date:5/16/2013)... , May 16, 2013 Developers of a pill ... reminders have emerged as grand prize winners in the ... funded by Boehringer Ingelheim and organized by HITLAB . ... , John Langhauser and ... the United States will receive $50,000 ...
Breaking Medicine Technology:OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5
... Johnson & Johnson Pharmaceutical,Research & Development, L.L.C. ... showed that investigational antibiotic ceftobiprole was found to,clinically ... -- including,some infections that were caused by methicillin-resistant ... the 45th annual meeting of the Infectious,Disease Society ...
... 3 clinical development program will examine HZT-501 as ... NSAID for mild to moderate pain -, ... Inc., a,privately held biopharmaceutical company, today announced that ... (protocol HZ-CA-304) of its lead,product candidate HZT-501, an ...
Cached Medicine Technology:New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections 2New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections 3New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections 4Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501 2Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501 3
Rapid Infectious Mononucleosis Heterophile Antibody (IgM) Test...
Unitary one step immuno-chromatographic assay for the qualitative detection of infectious mononucleosis heterophile antibodies in human serum, plasma or whole blood....
A simple, in-office test for the detection of mononucleosis. Easy to use with fast, accurate results within minutes....
... Burgdorferi Antibody Detection Assay is a single ... presumptive (first step) detection of IgG and ... serum or whole blood. Rapid turnaround time, ... the Wampole PreVue B. burgdorferi antibody detection ...
Medicine Products: